| Related LncRNAs | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| ID | lncRNA Name | Disease | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | Source |
| EL0017 | AB074278 | urothelial carcinoma of the bladder | microarray, qPCR, in vitro knockdown etc. | urothelial carcinoma of the bladder tissue | up-regulated | N/A | We implicate upregulation of AB074278 in apoptosis avoidance and the maintenance of a proproliferative state in cancer through a potential interaction with EMP1, a tumor suppressor and a negative regulator of cell proliferation. | 25165097 | LncRNADisease Lnc2Cancer |
| EL0853 | MALAT1 | urothelial carcinoma of the bladder | qPCR, knockdown etc. | cell lines (T24, 5737) | up-regulated | N/A | MALAT1 was upregulated in bladder urothelial carcinoma compared with matched normal urothelium (P=.008). The MALAT1 expression levels were greater in high-grade carcinomas than in low-grade carcinoma (P=.001). The MALAT1 expression levels were greater in invasive carcinoma than in noninvasive carcinoma (P=.018). MALAT1 plays an oncogenic role in urothelial carcinoma of the bladder. | 23153939 | Lnc2Cancer |
| EL1399 | TUG1 | urothelial carcinoma of the bladder | qPCR, knockdown etc. | cell lines (T24, 5637 etc. | up-regulated | expression | Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder. | 22961206 | LncRNADisease Lnc2Cancer |